2Myerburg RJ, Mitrani R, Interian JRA, et al. Eraluation of Pharmacologyical and device therapy for the management of life threatening arrhythrnias. Eur Heart J,1999, ( 1 ) :21
1[1]Chow M S. Intravenous amiodarone: Pharmacology,pharmacokinetics and clinical use. Ann Pharmacother,1996,30(6) :637-643.
2[2]Scheinman M M, Levine J H, Cannom D S, et al. Doseranging study of intravenous amiodarone in patients with life-threatenning ventricular tachyarrhythmias. Circulation, 1995,92(11) :3264-3272.
3[3]Levine J H, Massumi A, Scheinman M M, et al.Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol, 1996,27(1) :67-75.
4[4]Hohnloser S H, Singh B N. Proarrhythmia with class Ⅲantiarrhythmic drugs: Definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol, 1995,6(10 Pt 2):920-936.
